SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-093924
Filing Date
2020-08-12
Accepted
2020-08-12 16:32:15
Documents
16
Period of Report
2020-08-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2027319-1_8k.htm   iXBRL 8-K 37196
2 EXHIBIT 1.1 tm2027319d1_ex1-1.htm EX-1.1 172541
3 EXHIBIT 4.1 tm2027319d1_ex4-1.htm EX-4.1 391714
4 EXHIBIT 4.2 tm2027319d1_ex4-2.htm EX-4.2 170240
5 EXHIBIT 5.1 tm2027319d1_ex5-1.htm EX-5.1 26132
  Complete submission text file 0001104659-20-093924.txt   1129160

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA regn-20200807.xsd EX-101.SCH 3189
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE regn-20200807_lab.xml EX-101.LAB 34591
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE regn-20200807_pre.xml EX-101.PRE 22712
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2027319-1_8k_htm.xml XML 3523
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19034 | Film No.: 201095845
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences